UroGen Pharma Ltd

XNAS: URGN

Download real time

9.66 -0.01 (-0.10%)

53.33% Fall from 52W High

469.3K XNAS Volume

XNAS 21 Apr, 2025 5:30 PM (EDT)

445.3

Market Cap

Below industry Median

-0.2

Beta 1Year

Very Low volatility

UroGen Pharma Ltd - URGN - stock price prediction, stock price target, analyst ratings from 7 analysts

UroGen Pharma Ltd has a share price target of US$ 34, revenue growth forecast of 34.6%, and profit growth estimate of -4.8% for FY25, based on top 7 analyst calls.

Forecaster Screeners